TY - JOUR
T1 - A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan
T2 - 2011–2015 update
AU - Tateishi, Ryosuke
AU - Uchino, Koji
AU - Fujiwara, Naoto
AU - Takehara, Tetsuo
AU - Okanoue, Takeshi
AU - Seike, Masataka
AU - Yoshiji, Hitoshi
AU - Yatsuhashi, Hiroshi
AU - Shimizu, Masahito
AU - Torimura, Takuji
AU - Moriyama, Mitsuhiko
AU - Sakaida, Isao
AU - Okada, Hiroyuki
AU - Chiba, Tetsuhiro
AU - Chuma, Makoto
AU - Nakao, Kazuhiko
AU - Isomoto, Hajime
AU - Sasaki, Yutaka
AU - Kaneko, Shuichi
AU - Masaki, Tsutomu
AU - Chayama, Kazuaki
AU - Koike, Kazuhiko
N1 - Funding Information:
This research was supported by AMED under Grant Number JP17fk0210304 and JP18fk0210040 and the Health, Labour and Welfare Policy Research Grants from the Ministry of Health, Labour, and Welfare of Japan (Policy Research for Hepatitis Measures [H30-Kansei-Shitei-003]). The following investigators enrolled patients in the Inuyama NOBLESSE Study: Hiroshi Aikata (Hiroshima University, Hiroshima); Kyoko Oura (Kagawa University, Takamatsu); Masaaki Kitahara (Kanazawa University, Kanazawa); Motohiko Tanaka (Kumamoto University, Kumamoto); Kenji Oyama (Tottori University, Yonago); Naota Taura (Nagasaki University, Nagasaki); Hiroko Ito (Yokohama City University Medical Center, Yokohama); Akinobu Tawada (Chiba University, Chiba); Shinichiro Nakamura (Okayama University, Okayama); Issei Saeki (Yamaguchi University, Ube); Yasuo Arakawa (Nihon University); Takumi Kawaguchi (Kurume University, Kurume); Koji Takai (Gifu University, Gifu); Shigemune Bekki (National Hospital Organization Nagasaki Medical Center, Nagasaki); Naotaka Shimozato (Nara Medical University, Kashihara); Koichi Honda (Oita University, Yufu); Toshihide Shima (Saiseikai Suita Hospital, Suita); Ryotaro Sakamori (Osaka University, Suita); Hiroki Nishikawa (Hyogo College of Medicine, Nishinomiya); Masatoshi Kudo, Naoshi Nishida (Kindai University, Sayama); Masahiro Arai, Toru Arano (Toshiba Hospital, Tokyo); Akira Kato (Shimonoseki Medical Center, Shimonoseki); Akio Ido, Tsutomu Tamai (Kagoshima University, Kagoshima); Yoichi Hiasa, Masashi Hirooka (Ehime University, Toon); Sumio Watanabe, Kazuyoshi Kon (Juntendo University, Tokyo); Shigetoshi Fujiyama, Shiho Miyase (Kumamoto Shinto General Hospital, Kumamoto); Hideyuki Nomura, Nobuyuki Yamashita (Shin-Kokura Hospital, Kitakyushu); Yasuhito Tanaka, Etsuko Iio (Nagoya City University, Nagoya); Keisuke Hino, Yasuyuki Tomiyama (Kawasaki Medical School, Kurashiki).
Publisher Copyright:
© 2018, The Author(s).
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Background: We previously reported that the incidence of hepatocellular carcinoma (HCC) with non-viral etiologies increased rapidly between 1991 and 2010 in Japan. Methods: To update this investigation, we enrolled patients who were initially diagnosed as having non-B, non-C HCC at participating hospitals between 2011 and 2015. In addition to the patient characteristics investigated in the previous report, we also investigated the duration of alcohol consumption. The overall survival rate was analyzed using the Kaplan–Meier method, and the hazard function against the body mass index (BMI) was plotted using cubic splines. Results: A total of 2087 patients were enrolled. The proportion of patients with non-viral etiologies has continued to increase from 10.0% in 1991 to 32.5% in 2015. Patients were also older (median ages, 70–73 years) and more obese (median BMIs, 23.9–24.2 kg/m 2 ), and the proportions of patients with diabetes mellitus (46.1% to 51.6%), hypertension (42.7% to 58.6%), dyslipidemia (14.6% to 22.9%), and fatty liver (24.0% to 28.8%) had all increased significantly. There was a significant inverse relationship between the duration and the amount of daily alcohol consumption. The improvement in the overall survival was relatively small, with a decreased proportion of patients under surveillance (41.3% to 31.6%). A hazard function plot showed a curve similar to that in our previous report, with a lowest hazard of ~ 26 kg/m 2 . Conclusions: The proportion of HCC patients with non-viral etiologies continues to increase in Japan. Lifetime total amount of alcohol consumption may be a risk factor.
AB - Background: We previously reported that the incidence of hepatocellular carcinoma (HCC) with non-viral etiologies increased rapidly between 1991 and 2010 in Japan. Methods: To update this investigation, we enrolled patients who were initially diagnosed as having non-B, non-C HCC at participating hospitals between 2011 and 2015. In addition to the patient characteristics investigated in the previous report, we also investigated the duration of alcohol consumption. The overall survival rate was analyzed using the Kaplan–Meier method, and the hazard function against the body mass index (BMI) was plotted using cubic splines. Results: A total of 2087 patients were enrolled. The proportion of patients with non-viral etiologies has continued to increase from 10.0% in 1991 to 32.5% in 2015. Patients were also older (median ages, 70–73 years) and more obese (median BMIs, 23.9–24.2 kg/m 2 ), and the proportions of patients with diabetes mellitus (46.1% to 51.6%), hypertension (42.7% to 58.6%), dyslipidemia (14.6% to 22.9%), and fatty liver (24.0% to 28.8%) had all increased significantly. There was a significant inverse relationship between the duration and the amount of daily alcohol consumption. The improvement in the overall survival was relatively small, with a decreased proportion of patients under surveillance (41.3% to 31.6%). A hazard function plot showed a curve similar to that in our previous report, with a lowest hazard of ~ 26 kg/m 2 . Conclusions: The proportion of HCC patients with non-viral etiologies continues to increase in Japan. Lifetime total amount of alcohol consumption may be a risk factor.
KW - Alcoholic liver disease
KW - Hepatocellular carcinoma
KW - Non-alcoholic fatty liver disease
UR - http://www.scopus.com/inward/record.url?scp=85057581148&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057581148&partnerID=8YFLogxK
U2 - 10.1007/s00535-018-1532-5
DO - 10.1007/s00535-018-1532-5
M3 - Article
C2 - 30498904
AN - SCOPUS:85057581148
SN - 0944-1174
VL - 54
SP - 367
EP - 376
JO - Journal of Gastroenterology
JF - Journal of Gastroenterology
IS - 4
ER -